Heartcore Enterprises, Inc. current report, 13 April 2022

Full document

HeartCore Enterprises, Inc. Form 8-K Summary

Business Context and Reporting Period

HeartCore Enterprises, Inc. filed a Current Report on Form 8-K regarding a material consulting agreement entered into on April 13, 2022, with A.L.I. Technologies Inc. The report was signed and dated May 11, 2022. HeartCore is a Delaware corporation listed on Nasdaq under the symbol HTCR.

Material Agreement and Financial Terms

  • HeartCore agreed to provide A.L.I. with consulting and support services related to a potential U.S. IPO or de-SPAC transaction, including listing preparation, internal-control documentation, U.S. GAAP conversion, translation, audit-firm support, S-1 or S-4 preparation, website development, and investor presentation materials.
  • The agreement has a six-month term and provides for cash compensation of $400,000: $200,000 on the effective date, $100,000 after three months, and $100,000 after six months.
  • A.L.I. also issued HeartCore a warrant initially representing 1% of A.L.I.’s fully diluted share capital, subject to adjustment. The warrant has a $0.01-per-share exercise price, may be exercised after a qualifying A.L.I. U.S. IPO, expires ten years after the IPO date, and includes a 9.99% equity blocker.
  • Services beyond the six-month term will be billed at $150 per hour.

Material Changes, Outlook, and Risks

  • In a May 11, 2022 press release, HeartCore announced engagements with two private companies for its “Go IPO” consulting offering and stated that the engagements were expected to generate aggregate initial fee sales of $860,000.
  • HeartCore disclosed warrants representing 3% of Moveaction Co., Ltd.’s common stock on a fully diluted basis and 1% of A.L.I.’s common stock on a fully diluted basis.
  • The filing does not provide consolidated revenue, net income, cash flow, margins, debt, liquidity, or other period-specific financial statement metrics.
  • The anticipated fees and warrant values are not presented as recognized revenue or realized gains in this filing. The filing text does not provide a clear accounting treatment or valuation for the warrants.
  • HeartCore cannot guarantee that the engaged companies will complete an IPO, satisfy Nasdaq listing standards, or obtain listing approval.
  • HeartCore stated that it will not provide accounting services, act as an investment adviser or broker-dealer, negotiate securities sales, participate in investor discussions, structure securities transactions, pre-screen investors, conduct due diligence, or advise on investment valuation or financial advisability.

Key Facts Investors Should Verify

  • Whether A.L.I. or the other engaged companies ultimately complete qualifying IPOs or Nasdaq listings.
  • Whether the disclosed $400,000 A.L.I. fee and expected $860,000 aggregate initial fees are collected and recognized in subsequent financial statements.
  • The terms, valuation, dilution effects, and exercisability of the A.L.I. and Moveaction warrants.
  • Whether the six-month consulting agreement was renewed or generated additional hourly fees.
  • Subsequent disclosures regarding regulatory limitations, client execution risk, and HeartCore’s liquidity and operating results.